Ebola virus

5th Annual NTD/EID Workshop

5th Annual NTD/EID Computational Vaccinology Workshop May 15th – 19th, 2017 iCubed, 80 Washington Street  Providence RI, United States   The Institute for Immunology and Informatics (iCubed) will once again be hosting our training workshop in vaccine design for Neglected Tropical … Continue reading

Posted in Events, News | Tagged , , , , , , , , | Leave a comment
2013-03-16-HPsakura01

EpiVax at Bio Asia 2017

Lucky us! the 13th International Bio Asia Conference is scheduled for March 14-15, 2017 at the Grand Hyatt, Tokyo in Roppongi. It might be a bit early for cherry blossoms, but hope springs eternal! We will be arriving a bit early and staying … Continue reading

Posted in Events, News | Tagged , , , , , , , , , , , , , , , , , , , , | Leave a comment
zuben-sauna-fvii-mutation-analysis-2017

Our Prediction for 2017: Out with Post Hoc and Go DeFT! 

It’s a new year and welcome to it! Pundits are making a lot of predictions about the decline of science and technology under the new administration in Washington DC, and I’m here with a contrarian view. We bet on biotechnology! We predict … Continue reading

Posted in Blog, Featured, News | Tagged , , , , , , | Leave a comment
photo

Will EpiVax Tools be the Ancer to Cancer?

EpiVax Oncology – New Year, New Endeavor! A nice story in ConvergenceRI that describes the rapid growth of EpiVax and our decision to invest in a new spin-out company in 2017: Welcome EpiVax Oncology! Annie was interviewed by Richard Asinof … Continue reading

Posted in News | Tagged , , , , , , , , , , , , , , | Leave a comment
tularemia bacteria

$1.87M BioDefense Grant to EpiVax and CUBRC

CUBRC and EpiVax Awarded DTRA Grant worth $1.87 Million to Perform Research into Vaccine Antigen Design for Burkholderia pseudomallei Buffalo, NY – December 19, 2017 – CUBRC, Inc.’s President and CEO, Tom McMahon, announced today that CUBRC’s Biological and Medical … Continue reading

Posted in Featured, News | Tagged , , , , , , | Leave a comment
epivax-logo

The Ancer to Cancer: A computational pipeline for personalized cancer vaccine design

Building on 18 years of commercially successful research and development in the field of computational immunology, EpiVax has now developed Ancer™, a personalized cancer vaccine platform. Ancer is a high-speed, secure, cloud-based commercial platform for processing cancer/normal protein sets, identifying … Continue reading

Posted in Blog, EpiVax Immunoncology, Featured, News | Tagged , , , , , , , , , , , , | Leave a comment
bioeurope-spring

Bio-Europe Spring

EpiVax will be joining more than 1,400 companies from over 45 countries at Bio-Europe Spring, the premier springtime partnering conference bringing together a “whoʼs who” from biotech, pharma and finance in Europe’s most innovative biopharma clusters. Partner with us to … Continue reading

Posted in Blog, Events, Featured, News | Tagged , , , , , , | Leave a comment
H7N9

EpiVax to Advance Development of Vaccine Against Stealth Flu Virus with New NIH-SBIR Funding

September 6, 2016 (Providence, RI) – EpiVax, Inc., “immune engineering” pioneer, has won a new $600,000 National Institutes of Health grant under the Small Business Innovation Research (SBIR) program to improve a vaccine for the problematic H7N9 avian influenza virus. The … Continue reading

Posted in Featured, News | Tagged , , , , , | Leave a comment
VIE-Awards-LOGO-smaller

Biotech CEO of the Year

Standards of excellence. Models of advocacy. An unparalleled ability to succeed. These are characteristics of the vaccine industry’s top achievers. Last night at the 9th Vaccine Industry Excellence (ViE) Awards, winners were recognized for their outstanding contributions to the vaccine industry over the past 12-months. EpiVax’s … Continue reading

Posted in Blog, Featured, News | Tagged , , , , | Leave a comment

AAPS Biotechnology Conference May 2016

http://www.aaps.org/nationalbiotech/ Continue reading

Posted in Events, News | Leave a comment